Robert J. Silverman

Robert J. Silverman is a director and strategic advisor to the company since 2013. He served as the CEO of mtm laboratories AG, an in-vitro diagnostics company that developed and commercialized a portfolio of products for the early detection and diagnosis of cervical cancer. Bob was instrumental in raising capital and building mtm laboratories into a global, fully-integrated commercial business. He led the company to a $240 Million exit to Roche Diagnostics. Prior to leading mtm laboratories, he held senior executive positions at Viacell, Cytyc Corporation, Pasteur Merieux and Abbott Laboratories Pharmaceuticals. While Bob was a part of the Cytyc Management Team, the publicly traded value of the company grew from $150MM to $3BB, and ultimately Cytyc was sold to Hologic for $6.2BB. He earned his Master’s Degree in Marketing and Finance from the Kellogg Graduate School of Management at Northwestern University. Bob received his B.S. in Pharmacy from the University of Michigan. He currently works with several life science companies in a Board and Advisory capacity.